DSDs |
Differences of sexual development |
EDCs |
Endocrine disrupting chemicals |
TDS |
Testicular dysgenesis syndrome |
POI |
Premature ovarian insufficiency |
PCOS |
Polycystic ovary syndrome |
ER |
Oestrogen receptor |
NT2/D1 |
NTERA-2 clone D1 |
SOX9 |
Sex-determining region Y box transcription factor 9 |
SRY |
Sex-determining region Y |
AMH |
Anti-Mullerian hormone |
FGF9 |
Fibroblast growth factor |
PTGDS |
Prostaglandin D synthase |
SF1 |
Steroidogenic factor 1 |
FOXL2 |
Forkhead box L2 |
RSPO1 |
R-spondin 1 |
WNT4 |
Wnt family member 4 |
FST |
Follistatin |
BMP2 |
Bone morphogenetic protein 2 |
ERK1/2 |
Extracellular regulated kinases 1/2 |
MAP3K |
Mitogen-activated protein kinase kinase kinase |
GATA4 |
GATA binding protein 4 |
RHOA |
Ras homolog family member A |
ROCK |
Rho-associated coiled coil containing protein kinase |
RAC1 |
Rac family small GTPase 1 |
GSK3β |
Glycogen synthase kinase 3β |
FRAT1 |
FRAT regulator of Wnt signalling pathway 1 |
GADD45γ |
Growth arrest and DNA damage-inducible protein γ |
PKA |
Protein kinase A |
AKT |
AKT serine/threonine kinase |
PAK1 |
p21 (RAC1) activated kinase 1 |